Bloomage BioTechnology Corporation Limited (SHA:688363)
China
· Delayed Price · Currency is CNY 43.35
+0.11 (0.25%)
Apr 29, 2026, 3:00 PM CST
SHA:688363 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 291.15 | 174.27 | 592.56 | 970.92 | 782.33 | Upgrade
|
| Depreciation & Amortization | 357.82 | 293.87 | 264.65 | 213.61 | 154.33 | Upgrade
|
| Other Amortization | 33.18 | 36.31 | 27.74 | 15.04 | 6.96 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.22 | 0.12 | 3.42 | 0.49 | -0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | 90.59 | 74.95 | 1.87 | 0.28 | 33.73 | Upgrade
|
| Loss (Gain) From Sale of Investments | 5.47 | 11.48 | 17.41 | -11.77 | -28.04 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 26.01 | 7.6 | 15.36 | 5.78 | Upgrade
|
| Other Operating Activities | 39.87 | 85.03 | 30.02 | -1.72 | -1.65 | Upgrade
|
| Change in Accounts Receivable | -38.99 | -86.55 | 54.48 | -98.43 | -36.27 | Upgrade
|
| Change in Inventory | 162.15 | -141.49 | 13.88 | -437.82 | -218.53 | Upgrade
|
| Change in Accounts Payable | -327.97 | 98.06 | -321.54 | -72.85 | 613.39 | Upgrade
|
| Change in Other Net Operating Assets | -5.28 | 11.54 | 42.5 | 103.85 | 114.25 | Upgrade
|
| Operating Cash Flow | 627.45 | 564.51 | 699.65 | 635.19 | 1,276 | Upgrade
|
| Operating Cash Flow Growth | 11.15% | -19.32% | 10.15% | -50.22% | 80.97% | Upgrade
|
| Capital Expenditures | -325.68 | -721.39 | -1,030 | -696.41 | -784.21 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.07 | 0.21 | 0 | 1.24 | 0.01 | Upgrade
|
| Cash Acquisitions | - | - | - | -155.15 | -138.09 | Upgrade
|
| Divestitures | - | - | - | 0.12 | - | Upgrade
|
| Investment in Securities | -68.72 | 227.02 | 403.67 | -11.17 | -100.1 | Upgrade
|
| Other Investing Activities | 127.46 | 32.79 | 13.78 | 25.15 | 32.53 | Upgrade
|
| Investing Cash Flow | -264.87 | -461.37 | -612.88 | -836.22 | -989.86 | Upgrade
|
| Long-Term Debt Issued | 310.28 | 149.9 | - | 137.83 | 174 | Upgrade
|
| Total Debt Issued | 310.28 | 149.9 | - | 137.83 | 174 | Upgrade
|
| Long-Term Debt Repaid | -202.63 | -160.4 | -173.91 | -84.62 | -54.32 | Upgrade
|
| Total Debt Repaid | -202.63 | -160.4 | -173.91 | -84.62 | -54.32 | Upgrade
|
| Net Debt Issued (Repaid) | 107.65 | -10.51 | -173.91 | 53.21 | 119.68 | Upgrade
|
| Issuance of Common Stock | - | - | 51.72 | 84.21 | - | Upgrade
|
| Repurchase of Common Stock | - | -114.08 | -105.89 | - | - | Upgrade
|
| Common Dividends Paid | -56.08 | -185.93 | -305.48 | -242.86 | -201.01 | Upgrade
|
| Other Financing Activities | -53.87 | - | 6 | -64.71 | 9.98 | Upgrade
|
| Financing Cash Flow | -2.3 | -310.52 | -527.57 | -170.16 | -71.36 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4 | 7.81 | 10.56 | 29.56 | -19.85 | Upgrade
|
| Net Cash Flow | 364.28 | -199.57 | -430.24 | -341.63 | 194.99 | Upgrade
|
| Free Cash Flow | 301.77 | -156.88 | -330.68 | -61.22 | 491.85 | Upgrade
|
| Free Cash Flow Margin | 7.19% | -2.92% | -5.44% | -0.96% | 9.94% | Upgrade
|
| Free Cash Flow Per Share | 0.63 | -0.32 | -0.69 | -0.13 | 1.02 | Upgrade
|
| Cash Income Tax Paid | 226.04 | 480.27 | 550.54 | 770.79 | 539.9 | Upgrade
|
| Levered Free Cash Flow | 370.35 | -285.68 | -624.83 | -240.37 | 940.17 | Upgrade
|
| Unlevered Free Cash Flow | 370.35 | -279.95 | -618.13 | -231.29 | 947.09 | Upgrade
|
| Change in Working Capital | -190.41 | -137.54 | -245.63 | -567.02 | 322.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.